Skip to content

Author

Ying Liu

We have 2 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

FTSJ3‐Mediated 2′‐O‐Methylation of HSPA5 mRNA Stabilizes BOP1 via SUMOylation to Drive DRP1‐Dependent Mitochondrial Fission and Fatty Acid Oxidation in Lung Squamous Cell Carcinoma

A novel FTSJ3‐HSPA5‐BOP1‐DRP1‐SREBP1‐SREBP1 axis that integrates RNA methylation with SUMOylation, mitochondrial dynamics and lipid metabolism to promote LUSC progression is delineated, nominating FTSJ3 as a therapeutic target for this cancer.

Qin Hu, Jia-Heng Lin, Yi-Fei Zhu et al. · 0 citations
Review Open access Jul 2026

Antibody–drug conjugates in non-small cell lung cancer: current landscape and future directions

This review summarizes the latest clinical progress of ADCs in NSCLC, highlighting key agents and their impact, while also addressing the associated challenges and future directions for optimizing this promising treatment modality.

Xi Chen, Si-Rui Wu, Fei-Yang Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.